CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools & models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.CXO perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top investment pockets

3.3.Porter's five forces analysis
3.4.Top player positioning, 2019
3.5.Market dynamics

3.5.1.Drivers

3.5.1.1.Rise in prevalence of infectious diseases and cancer
3.5.1.2.Increase in awareness and acceptance of personalized medicines
3.5.1.3.Technological advancements

3.5.2.Restraints

3.5.2.1.High cost of dPCR devices
3.5.2.2.Reimbursement issues

3.5.3.Opportunity

3.5.3.1.Increase in funding for R&D activities

3.6.Impact analysis of COVID-19 on the digital PCR market

CHAPTER 4:DIGITAL POLYMERASE CHAIN REACTION MARKET, BY TECHNOLOGY

4.1.Overview

4.1.1.Market size and forecast

4.2.Droplet digital PCR

4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast
4.2.3.Market analysis, by country

4.3.BEAMing dPCR

4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast
4.3.3.Market analysis, by country

CHAPTER 5:DIGITAL POLYMERASE CHAIN REACTION MARKET, BY PRODUCT TYPE

5.1.Overview

5.1.1.Market size and forecast

5.2.Consumables & reagents

5.2.1.Market size and forecast
5.2.2.Market analysis, by country

5.3.Digital PCR systems

5.3.1.Market size and forecast
5.3.2.Market analysis, by country

5.4.Software & services

5.4.1.Market size and forecast
5.4.2.Market analysis, by country

CHAPTER 6:DIGITAL POLYMERASE CHAIN REACTION MARKET, BY APPLICATION

6.1.Overview

6.1.1.Market size and forecast

6.2.Research

6.2.1.Market size and forecast
6.2.2.Market analysis, by country

6.3.Clinical diagnostics

6.3.1.Market size and forecast
6.3.2.Market analysis, by country

6.4.Forensic & others

6.4.1.Market size and forecast
6.4.2.Market analysis, by country

CHAPTER 7:DIGITAL POLYMERASE CHAIN REACTION MARKET, BY END USER

7.1.Overview

7.1.1.Market size and forecast

7.2.Clinical diagnostic laboratories

7.2.1.Market size and forecast
7.2.2.Market analysis, by country

7.3.Pharmaceuticals & biotechnology industries

7.3.1.Market size and forecast
7.3.2.Market analysis, by country

7.4.Universities & other organizations

7.4.1.Market size and forecast
7.4.2.Market analysis, by country

CHAPTER 8:DIGITAL POLYMERASE CHAIN REACTION MARKET, BY REGION

8.1.OVERVIEW

8.1.1.Market size and forecast

8.2.North America

8.2.1.Key market trends and opportunities
8.2.2.North America digital PCR market, by country

8.2.2.1.U.S. digital PCR market, by technology
8.2.2.2.U.S. digital PCR market, by product type
8.2.2.3.U.S. digital PCR market, by application
8.2.2.4.U.S. digital PCR market, by end user
8.2.2.5.Canada digital PCR market, by technology
8.2.2.6.Canada digital PCR market, by product type
8.2.2.7.Canada digital PCR market, by application
8.2.2.8.Canada digital PCR market, by end user
8.2.2.9.Mexico digital PCR market, by technology
8.2.2.10.Mexico digital PCR market, by product type
8.2.2.11.Mexico digital PCR market, by application
8.2.2.12.Mexico digital PCR market, by end user

8.2.3.North America digital PCR market, by technology
8.2.4.North America digital PCR market, by product type
8.2.5.North America digital PCR market, by application
8.2.6.North America digital PCR market, by end user

8.3.Europe

8.3.1.Key market trends and opportunities
8.3.2.Europe digital PCR market, by country

8.3.2.1.Germany digital PCR market, by technology
8.3.2.2.Germany digital PCR market, by product type
8.3.2.3.Germany digital PCR market, by application
8.3.2.4.Germany digital PCR market, by end user
8.3.2.5.France digital PCR market, by technology
8.3.2.6.France digital PCR market, by product type
8.3.2.7.France digital PCR market, by application
8.3.2.8.France digital PCR market, by end user
8.3.2.9.UK digital PCR market, by technology
8.3.2.10.UK digital PCR market, by product type
8.3.2.11.UK digital PCR market, by application
8.3.2.12.UK digital PCR market, by end user
8.3.2.13.Italy digital PCR market, by technology
8.3.2.14.Italy digital PCR market, by product type
8.3.2.15.Italy digital PCR market, by application
8.3.2.16.Italy digital PCR market, by end user
8.3.2.17.Spain digital PCR market, by technology
8.3.2.18.Spain digital PCR market, by product type
8.3.2.19.Spain digital PCR market, by application
8.3.2.20.Spain digital PCR market, by end user
8.3.2.21.Rest of Europe digital PCR market, by technology
8.3.2.22.Rest of Europe digital PCR market, by product type
8.3.2.23.Rest of Europe digital PCR market, by application
8.3.2.24.Rest of Europe digital PCR market, by end user

8.3.3.Europe digital PCR market, by technology
8.3.4.Europe digital PCR market, by product type
8.3.5.Europe digital PCR market, by application
8.3.6.Europe digital PCR market, by end user

8.4.Asia-Pacific

8.4.1.Key market trends and opportunities
8.4.2.Asia-Pacific digital PCR market, by country

8.4.2.1.Japan digital PCR market, by technology
8.4.2.2.Japan digital PCR market, by product type
8.4.2.3.Japan digital PCR market, by application
8.4.2.4.Japan digital PCR market, by end user
8.4.2.5.China digital PCR market, by technology
8.4.2.6.China digital PCR market, by product type
8.4.2.7.China digital PCR market, by application
8.4.2.8.China digital PCR market, by end user
8.4.2.9.Australia digital PCR market, by technology
8.4.2.10.Australia digital PCR market, by product type
8.4.2.11.Australia digital PCR market, by application
8.4.2.12.Australia digital PCR market, by end user
8.4.2.13.India digital PCR market, by technology
8.4.2.14.India digital PCR market, by product type
8.4.2.15.India digital PCR market, by application
8.4.2.16.India digital PCR market, by end user
8.4.2.17.South Korea digital PCR market, by technology
8.4.2.18.South Korea digital PCR market, by product type
8.4.2.19.South Korea digital PCR market, by application
8.4.2.20.South Korea digital PCR market, by end user
8.4.2.21.Taiwan digital PCR market, by technology
8.4.2.22.Taiwan digital PCR market, by product type
8.4.2.23.Taiwan digital PCR market, by application
8.4.2.24.Taiwan digital PCR market, by end user
8.4.2.25.Rest of Asia-Pacific digital PCR market, by technology
8.4.2.26.Rest of Asia-Pacific digital PCR market, by product type
8.4.2.27.Rest of Asia-Pacific digital PCR market, by application
8.4.2.28.Rest of Asia-Pacific digital PCR market, by end user

8.4.3.Asia-Pacific digital PCR market, by technology
8.4.4.Asia-Pacific digital PCR market, by product type
8.4.5.Asia-Pacific digital PCR market, by application
8.4.6.Asia-Pacific digital PCR market, by end user

8.5.LAMEA

8.5.1.Key market trends and opportunities
8.5.2.LAMEA digital PCR market, by country

8.5.2.1.Brazil digital PCR market, by technology
8.5.2.2.Brazil digital PCR market, by product type
8.5.2.3.Brazil digital PCR market, by application
8.5.2.4.Brazil digital PCR market, by end user
8.5.2.5.Saudi Arabia digital PCR market, by technology
8.5.2.6.Saudi Arabia digital PCR market, by product type
8.5.2.7.Saudi Arabia digital PCR market, by application
8.5.2.8.Saudi Arabia digital PCR market, by end user
8.5.2.9.South Africa digital PCR market, by technology
8.5.2.10.South Africa digital PCR market, by product type
8.5.2.11.South Africa digital PCR market, by application
8.5.2.12.South Africa digital PCR market, by end user
8.5.2.13.Rest of LAMEA digital PCR market, by technology
8.5.2.14.Rest of LAMEA digital PCR market, by product type
8.5.2.15.Rest of LAMEA digital PCR market, by application
8.5.2.16.Rest of LAMEA digital PCR market, by end user

8.5.3.LAMEA digital PCR market, by technology
8.5.4.LAMEA digital PCR market, by product type
8.5.5.LAMEA digital PCR market, by application
8.5.6.LAMEA digital PCR market, by end user

CHAPTER 9:COMPANY PROFILES

9.1.BIO-RAD LABORATORIES, INC.

9.1.1.Company overview
9.1.2.Company snapshot
9.1.3.Operating business segments
9.1.4.Product portfolio
9.1.5.Business performance
9.1.6.Key strategic moves and developments

9.2.4BASEBIO AG

9.2.1.Company overview
9.2.2.Company snapshot
9.2.3.Operating business segments
9.2.4.Product portfolio
9.2.5.Business Performance

9.3.COMBINATI, INC.

9.3.1.Company overview
9.3.2.Company snapshot
9.3.3.Operating business segments
9.3.4.Product portfolio
9.3.5.Key strategic moves and developments

9.4.FLUIDIGM CORPORATION

9.4.1.Company overview
9.4.2.Company snapshot
9.4.3.Operating business segments
9.4.4.Product portfolio
9.4.5.Business performance

9.5.JN MEDSYS

9.5.1.Company overview
9.5.2.Company snapshot
9.5.3.Product portfolio
9.5.4.Key strategic moves and developments

9.6.MERCK KGAA

9.6.1.Company overview
9.6.2.Company snapshot
9.6.3.Operating business segments
9.6.4.Product portfolio
9.6.5.Business performance
9.6.6.Key strategic moves and developments

9.7.QIAGEN N.V.

9.7.1.Company overview
9.7.2.Company snapshot
9.7.3.Operating business segment
9.7.4.Product portfolio
9.7.5.Business performance
9.7.6.Key strategic moves and developments

9.8.SYSMEX CORPORATION

9.8.1.Company overview
9.8.2.Company snapshot
9.8.3.Operating business segments
9.8.4.Product portfolio
9.8.5.Business performance

9.9.STILLA TECHNOLOGIES

9.9.1.Company overview
9.9.2.Company snapshot
9.9.3.Product portfolio
9.9.4.Key strategic moves and developments

9.10.THERMO FISHER SCIENTIFIC, INC.

9.10.1.Company overview
9.10.2.Company snapshot
9.10.3.Operating business segments
9.10.4.Product portfolio
9.10.5.Business performance